278 related articles for article (PubMed ID: 22566579)
1. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.
Tiihonen J; Suokas JT; Suvisaari JM; Haukka J; Korhonen P
Arch Gen Psychiatry; 2012 May; 69(5):476-83. PubMed ID: 22566579
[TBL] [Abstract][Full Text] [Related]
2. Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.
Tiihonen J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Am J Psychiatry; 2016 Jun; 173(6):600-6. PubMed ID: 26651392
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Tan Z; Wall MM; Mathai C; Olfson M
JAMA Psychiatry; 2019 May; 76(5):508-515. PubMed ID: 30785609
[TBL] [Abstract][Full Text] [Related]
4. Description of long-term polypharmacy among schizophrenia outpatients.
Suokas JT; Suvisaari JM; Haukka J; Korhonen P; Tiihonen J
Soc Psychiatry Psychiatr Epidemiol; 2013 Apr; 48(4):631-8. PubMed ID: 23007295
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.
Fontanella CA; Campo JV; Phillips GS; Hiance-Steelesmith DL; Sweeney HA; Tam K; Lehrer D; Klein R; Hurst M
J Clin Psychiatry; 2016 May; 77(5):661-7. PubMed ID: 27249075
[TBL] [Abstract][Full Text] [Related]
6. Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia.
Haukka J; Tiihonen J; Härkänen T; Lönnqvist J
Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):686-96. PubMed ID: 18327869
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
9. Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.
Hulkko AP; Murray GK; Moilanen J; Haapea M; Rannikko I; Jones PB; Barnett JH; Huhtaniska S; Isohanni MK; Koponen H; Jääskeläinen E; Miettunen J
Eur Psychiatry; 2017 Sep; 45():50-58. PubMed ID: 28728095
[TBL] [Abstract][Full Text] [Related]
10. Mortality and use of psychotropic medication in sleep apnoea patients: a population-wide register-based study.
Jennum P; Baandrup L; Tønnesen P; Ibsen R; Kjellberg J
Sleep Med; 2018 Mar; 43():19-24. PubMed ID: 29482806
[TBL] [Abstract][Full Text] [Related]
11. [Mortality and cumulative exposure to antipsychotics, antidepressants and benzodiazepines in patients with schizophrenia: an observational follow-up study].
Tiihonenl J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Duodecim; 2016; 132(2):181. PubMed ID: 26939492
[No Abstract] [Full Text] [Related]
12. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
[No Abstract] [Full Text] [Related]
13. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.
Längle G; Steinert T; Weiser P; Schepp W; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Kilian R
Acta Psychiatr Scand; 2012 May; 125(5):372-81. PubMed ID: 22321029
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up.
Kiviniemi M; Suvisaari J; Koivumaa-Honkanen H; Häkkinen U; Isohanni M; Hakko H
Schizophr Res; 2013 Oct; 150(1):274-80. PubMed ID: 23953217
[TBL] [Abstract][Full Text] [Related]
15. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.
Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348
[TBL] [Abstract][Full Text] [Related]
16. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
[TBL] [Abstract][Full Text] [Related]
17. Long-term Psychoactive Medications, Polypharmacy, and Risk of Suicide and Unintended Overdose Death Among Midlife and Older Women Veterans.
Gibson CJ; Li Y; Jasuja GK; Keyhani S; Byers AL
J Gen Intern Med; 2022 Sep; 37(Suppl 3):770-777. PubMed ID: 36042093
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy in schizophrenia.
Baandrup L
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):183-192. PubMed ID: 31908124
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy for schizophrenia.
Ballon J; Stroup TS
Curr Opin Psychiatry; 2013 Mar; 26(2):208-13. PubMed ID: 23318662
[TBL] [Abstract][Full Text] [Related]
20. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
